Clinical Trial Update: A Phase 1b Trial to Evaluate the Safety of MB310 in Patients With Active, Mild-to-Moderate Ulcerative Colitis [Phase 1]

View source ↗

Summary

A Phase 1b trial evaluating the safety of MB310 in patients with active, mild-to-moderate ulcerative colitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Drugs mentioned

• MB310

Snippet

Sponsor: Microbiotica Ltd | Conditions: Ulcerative Colitis | Phase 1 | Status: COMPLETED